CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
Balance Sheets Overview
Current Ratio
136.13%
Quick Ratio
103.23%
Cash Ratio
17.54%
Debt to Asset Ratio
61.34%
Unit: Thousand (K) dollars
Assets Breakdown
Goodwill
Trade receivables and contract a...
Inventories
Others
Liabilities Breakdown
Long-term debt, net and finance ...
Additional paid-in capital
Retained earnings
Others
Balance Sheets
2026-03-28
2025-12-27
2025-09-27
2025-06-28
Cash and cash equivalents
191,830
213,770
207,097
182,824
Trade receivables and contract assets, net of allowances for credit losses of 8,114 and 10,463, respectively
700,251
708,856
734,482
767,569
Inventories
359,723
299,103
302,550
279,550
Prepaid assets
102,146
96,108
121,535
109,998
Other current assets
134,856
129,212
166,440
129,921
Total current assets
1,488,806
1,447,049
1,532,104
1,469,862
Property, plant and equipment, net
1,510,154
1,655,219
1,591,625
1,606,733
Venture capital and strategic equity investments
209,723
206,972
194,635
216,073
Operating lease right-of-use assets, net
317,840
361,415
374,273
385,756
Goodwill
3,040,032
2,764,253
2,922,281
2,936,265
Intangible assets, net
248,989
339,995
571,094
602,452
Deferred tax assets
88,599
67,334
36,907
46,943
Other assets
826,165
293,185
290,893
296,461
Total assets
7,730,308
7,135,422
7,513,812
7,560,545
Accounts payable
133,952
148,800
169,615
145,798
Accrued compensation
166,888
268,854
269,697
227,509
Deferred revenue
194,330
210,418
237,728
268,340
Accrued liabilities
372,397
270,085
228,895
231,567
Other current liabilities
226,137
222,158
215,953
207,224
Total current liabilities
1,093,704
1,120,315
1,121,888
1,080,438
Long-term debt, net and finance leases
2,663,133
2,136,360
2,185,453
2,332,374
Operating lease right-of-use liabilities
393,113
434,048
443,185
453,664
Deferred tax liabilities
81,399
95,203
123,007
109,273
Other long-term liabilities
510,646
138,302
189,462
185,210
Total liabilities
4,741,995
3,924,228
4,062,995
4,160,959
Redeemable noncontrolling interests
41,900
41,263
40,492
39,956
Common stock, 0.01 par value 120,000 shares authorized 49,342 shares issued and 48,167 shares outstanding as of march28, 2026, and 49,217 shares issued and outstanding as of december27, 2025
493
492
514
513
Additional paid-in capital
1,967,356
1,947,301
2,015,665
1,992,718
Retained earnings
1,373,777
1,388,620
1,944,317
1,889,895
Treasury stock, at cost, 1,175 and zero shares, as of march28, 2026 and december27, 2025, respectively
209,990
0
363,431
363,338
Accumulated other comprehensive loss
-191,042
-171,783
-191,616
-166,467
Total charles river laboratories international, inc. equity
2,940,594
3,164,630
3,405,449
3,353,321
Nonredeemable noncontrolling interest
5,819
5,301
4,876
6,309
Total equity
2,946,413
3,169,931
3,410,325
3,359,630
Total liabilities, redeemable noncontrolling interests and equity
7,730,308
7,135,422
7,513,812
7,560,545
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.